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Abstract
Pseudomonas aeruginosa and Staphylococcus aureus are thought to cause the majority of lung infections in patients with cystic ﬁbrosis
(CF). However, other bacterial pathogens may contribute to the pathophysiology of lung disease. Here, obligate anaerobes were identi-
ﬁed in a cross-sectional study, and cell numbers and antibiotic susceptibilities of facultative and obligate anaerobes from 114 sputum
samples from nine children and 36 adults with CF were determined. Furthermore, in 12 CF patients, we investigated whether conven-
tional intravenous antibiotic therapy, administered during acute exacerbations, would affect the numbers of obligate anaerobes. Fifteen
genera of obligate anaerobes were identiﬁed in 91% of the CF patients. Cell numbers (mean: 2.2 · 107 ± standard deviation
6.9 · 107 CFU/mL of sputum sample) were comparable to those of P. aeruginosa and S. aureus. Staphylococcus saccharolyticus and Pepto-
streptococcus prevotii were most prevalent. Infection with P. aeruginosa did not increase the likelihood that obligate anaerobes are present
in sputum specimens. Single obligate anaerobic species persisted for up to 11 months in sputum plugs in vivo. Patients with and without
obligate anaerobes in sputum specimens did not differ in lung function. Intravenous therapy directed against P. aeruginosa during acute
exacerbations increased lung function, but did not reduce the numbers of obligate anaerobes. Obligate anaerobic species differed widely
in their patterns of resistance against meropenem, piperacillin–tazobactam, clindamycin, metronidazole and ceftazidime. In 58% of
patients with acute exacerbations, obligate anaerobes were detected that were resistant to the antibiotics used for treatment. Antibiotic
therapy, optimized to target anaerobes in addition to P. aeruginosa, may improve the management of CF lung disease.
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Introduction
In patients with the hereditary disease cystic ﬁbrosis (CF),
the major reason for premature death is lung tissue destruc-
tion as a consequence of bacterial lung infection. Epidemio-
logical data show that the facultative anaerobic pathogens
Pseudomonas aeruginosa and Staphylococcus aureus are the
most prevalent bacterial species causing lung disease [1,2].
These pathogens colonize CF airways due to impaired innate
immune functions, secondary to mutations in the CF trans-
membrane conductance regulator gene [3,4]. In particular,
bioﬁlm formation within viscous, hypoxic mucous plugs [5]
and deposition of DNA on the respiratory epithelium [6] are
thought to facilitate chronic infection in CF patients. As
a response to the persisting pathogens, large numbers of
neutrophils enter the site of infection, decay and consider-
ably enlarge the volume of viscous sputum plugs. Oxygen
consumption by respiratory epithelial cells [7], bacteria [5]
and phagocytes [8] eventually leads to anaerobic
environmental conditions in the sputum [5], which further
impair innate immune functions [9] and compromise
antibiotic therapy [10–13].
Large anaerobic sputum plugs in airways of CF patients
may provide a perfect niche for obligate anaerobic bacterial
species. Indeed, Rogers et al. [14] detected 16S rRNA spe-
ciﬁc for various fastidious anaerobes in CF sputum. Similarly,
Harris et al. [15] identiﬁed rRNA of 65 different obligate
anaerobic bacterial species in bronchoalveolar lavage (BAL)
ﬂuids from 28 children with CF. Recently, Tunney et al. [16]
isolated obligate anaerobes of 14 different genera, including
Prevotella, Veillonella, Propionibacterium and Actinomyces, in 64%
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of sputum samples from adults with CF. This group also
found that obligate anaerobes were present in equal or
greater numbers than P. aeruginosa in 78% of sputum speci-
mens [16].
The rapidly growing interest of clinicians and researchers
in obligate anaerobes present in CF sputum specimens led to
a number of questions in this context. Do genera and spe-
cies of obligate anaerobes differ among CF centres? Does
infection with P. aeruginosa increase the likelihood that anaer-
obic bacteria will be present in CF sputum specimens? Do
obligate anaerobes persist in CF airways for longer periods
of time? Can obligate anaerobic bacteria also be found
in patients suffering from other pulmonary diseases? Do
obligate anaerobes play a role in the pathophysiology of CF
lung disease and affect lung function? Are cell numbers of
obligate anaerobes in CF airways comparable to those of
P. aeruginosa or S. aureus, and does the presence of obligate
anaerobes inﬂuence cell numbers of facultative anaerobes?
Does antibiotic therapy directed against P. aeruginosa
efﬁciently reduce the numbers of obligate anaerobes in CF
respiratory specimens? How sensitive are obligate anaerobes
to various antibiotics?
In response to these questions, obligate anaerobes were
identiﬁed and cell numbers and antibiotic susceptibilities
of facultative and obligate anaerobes were determined in
sputum and throat swab samples from children and adults
with CF. Furthermore, the antibiotic susceptibility pattern of
obligate anaerobes from CF patients was assessed, and lung
function in the patient cohort was determined. Finally, the
question of whether conventional intravenous antibiotic
therapy administered during acute exacerbations would affect
the numbers of facultative and obligate anaerobes, as well as
lung function, was addressed.
Patients and methods
Patients
Forty-ﬁve CF patients (18 male, 27 female; age 24.6 ± 9.7
years; range 6–64 years), attending the Children’s Hospital
(nine patients; age 6–18 years) and the Hospital of Internal
Medicine (36 patients; age 18–64 years) of the University
Hospital Halle, were included in the study. Diagnosis of CF
was conﬁrmed by sweat testing and/or genotyping. All
patients received tobramycin (2 · 300 mg/day inhaled) and/
or colistin (2 · 80 mg/day inhaled) plus oral azithromycin
(1 · 250 mg/day). Twelve patients suffered from acute
exacerbations, deﬁned according to the criteria of Fuchs
et al. [17], during the investigation period. These patients
received additional (in hospital or at home) intravenous
courses for 2 or 3 weeks with piperacillin–tazobactam
(3 · 1 amp./day), ceftazidime (3 · 2 g/day), meropenem
(3 · 1 g/day) or cefepim (3 · 2 g/day). From all 45 patients,
114 expectorated sputum samples were obtained. Within
30 min after collection, samples were processed in the labo-
ratory. Furthermore, throat swabs were obtained from
seven CF patients. For determination of oral contamination,
throat swabs of the pharynx were performed using phos-
phate-buffered saline-moistened cotton swabs following spu-
tum expectoration. Additionally, BAL ﬂuids from six children
(age 7.2 ± 5.3 years; range 2–16 years), attending the Chil-
dren’s Hospital of the University Hospital Halle, suffering
from pulmonary diseases other than CF were obtained. Five
of the patients suffered from acute pneumonia; one patient
had chronic retention pneumonia with purulent secretions
on the basis of perinatal cerebral insults and scoliosis.
Explorative BAL was performed as described previously [18].
All patients, or their parents, gave written informed consent.
The study was approved by the Ethical Committee of the
Medical Faculty of the Martin-Luther University Halle–
Wittenberg. The research was carried out in accordance
with the Helsinki Declaration.
Cell numbers of facultative and obligate anaerobic bacteria
in sputum samples of CF patients
For facultative anaerobes, sputum samples solubilized in
phosphate-buffered saline (1 : 1) were incubated in ten-fold
dilutions on Columbia agar (Oxoid, Basingstoke,UK), supple-
mented with sheep blood (10%), aerobically for 24 h
at 37C. For obligate anaerobes, sputum samples were
incubated in ten-fold dilutions on brain–heart infusion agar
(Heipha, Eppelheim, Germany) and Schaedler (SCS) agar
(BioMe´rieux, Marcy l´Etoile, France), supplemented with
sheep blood (5%), at 37C for up to 7 days in an anaerobic
box (MAKS MG500; Meintrup, La¨hden-Holte, Germany).
The oxygen-free gas mixture in the box contained 80%
nitrogen, 10% hydrogen and 10% carbon dioxide. Up to four
phenotypically different anaerobic strains were counted per
sputum specimen. An aliquot of 2 mL of BAL ﬂuid was used
for bacterial cultures.
Identiﬁcation of facultative and obligate anaerobic bacteria
in sputum samples of CF patients
For identiﬁcation of facultative anaerobes, single colonies
were plated on Columbia, Cetremide and McConkey agar
(Oxoid) and incubated aerobically for 24 h at 37C.
Thereafter, Gram staining was performed, and the bacteria
were tested for oxidase (Becton Dickinson, Sparks, MD,
USA), catalase (ID-Ase; BioMe´rieux) and protein A
(Staphaurex Plus; Remel, Lenexa, KS, USA). Further
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identiﬁcation was performed using the Vitek biochemical
identiﬁcation system (BioMe´rieux) and the Crystal system
(Becton Dickinson). Micro-aerophilic streptococci were
considered to represent upper-airway contamination and
were not included in the further evaluation [19,20]. All
strains quantiﬁed in the anaerobic box were incubated
aerobically to exclude facultative or aerotolerant
anaerobes. Only strains that did not grow aerobically were
analysed further. These bacteria were Gram-stained, and
identiﬁed employing the RapID Ana II (Remel) identiﬁ-
cation system and ERIC software (Electronic RapID
Compendium version 1.0, Remel).
For taxonomy and nomenclature [21], the recommenda-
tions of the manufacturers of the identiﬁcation systems were
used.
Antibiotic sensitivity testing of obligate anaerobes from CF
sputum samples
Sensitivity testing for 138 obligate anaerobic strains was
performed using SCS agar and the Etest (AB Biodisk,
Solna, Sweden). Breakpoints for the antibiotics were
according to the M11-A6 guideline (CLSI, Wayne, PA,
USA). The antibiotics clindamycin (breakpoint MIC: 2 mg/
L), metronidazole (8 mg/L), meropenem (4 mg/L), piperacil-
lin–tazobactam (32 mg/L) and ceftazidime (‡8 mg/L) were
tested. MICs were determined after 48 h of anaerobic
incubation according to the instructions of the manufac-
turers.
Determination of lung functions of CF patients
Lung function measurements were performed during quar-
terly routine visits of the CF patients in the outpatient clinic
of the University of Halle. For body plethysmography, the
MasterScreen Body (Jaeger, Hoechberg, Germany) was used.
Forced expiratory volume in 1 s (FEV1) and forced vital
capacity (FVC) were determined and expressed as percentage
of age-predicted lung function. During acute exacerbations,
the patients were subjected to additional measurements at
the beginning of the exacerbation and, at the latest, 2 weeks
(mean ± standard deviation (SD); 6 ± 5 days) after termina-
tion of the intravenous antibiotic course.
Statistics
For statistical analysis, raw data were checked for normality
using the Shapiro–Wilks test. Signiﬁcance (Student’s t-test)
and correlation (Pearson correlation coefﬁcient) values were
calculated using Excel (Microsoft, Redmont, WA, USA). A
p-value <0.05 was considered signiﬁcant. Results are given as
means ± SD.
Results
Identiﬁcation of facultative and obligate anaerobic bacteria
in sputum samples of CF patients and correlation with
P. aeruginosa infection status, persistence of single species
over time, other pulmonary diseases and CF lung function
To determine the prevalence of obligate anaerobes in CF
airways and to assess whether genera and species of obligate
anaerobes differed among CF centres, 114 sputum specimens
from 45 CF patients were analysed. In 41 of 45 CF patients
(91%), one or more obligate anaerobic species were
detected in sputum samples. Obligate anaerobes were pres-
ent at comparable rates in children younger than 18 years
(82%) and adults (94%). In the 93 positive sputum samples,
168 isolates were assigned to 16 obligate anaerobic genera,
with 35 species being identiﬁed in 13 genera (Table 1). Up
to four different species were found per sputum sample.
Species of Staphylococcus, Peptostreptococcus, Actinomyces,
Veillonella and Clostridium were detected in 37, 34, 19, 15 and
TABLE 1. Obligate anaerobic bacteria in sputum of cystic
ﬁbrosis patients
Genus N Species N
Staphylococcus 37 saccharolyticus 37
Peptostreptococcus 34 anaerobius 6
micros 1
prevotii 20
tetradius 7
Actinomyces 19 israelii 2
meyeri 3
naeslundii 1
odontolyticus 7
turicensis 6
Veillonella 15 spp. 15
Clostridium 12 bifermentans 1
butyricum 1
clostridioforme 2
difﬁcile 3
hastiforme 2
innocuum 1
perfringens 1
sporogenes 1
Bacteroides 7 tectum 6
stercoris 1
Mobiluncus 7 curtsii 1
mulieris 6
Streptococcus 7 constellatus 6
intermedius 1
Capnocytophaga 6 spp. 6
Gemella 5 morbillorum 5
Prevotella 4 corporis 2
melaninogenica 2
Eubacterium 3 aerofaciens 2
limosum 1
Fusobacterium 3 necrophorum 3
Lactobacillus 3 acidophilus 2
jensenii 1
Propionibacterium 3 acnes 1
granulosum 1
propionicum 1
Wolinella 3 spp. 3
Total 168 168
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12 different sputum specimens, respectively, and members of
11 other genera were found in the remaining 51 different
specimens (Table 1). Obligate anaerobes were detected in
sputum samples from 22 CF patients who were chronically
infected with P. aeruginosa. However, obligate anaerobes
were also present in sputum specimens of 19 patients with
S. aureus, in four with Burkholderia cepacia complex bacteria,
and in three with Stenotrophomonas maltophilia. Three
patients harboured two strains simultaneously. Thus, infec-
tion with P. aeruginosa does not seem to increase the likeli-
hood of the presence of obligate anaerobic bacteria in CF
sputum specimens.
Next, it was investigated whether obligate anaerobes
persist in CF airways for extended periods of time. From 26
of 45 patients, two or more sputum specimens taken at
different time-points were available. In 42% of the patients,
the same species was found repeatedly. In ﬁve patients, up
to four different obligate anaerobic species were cultured
simultaneously over a period of 6 months. Identical species
were re-identiﬁed in three patients for up to 11 months.
These results show that single obligate anaerobes are able to
persist in CF airways for extended periods of time.
To assess whether the presence of obligate anaerobic bac-
teria in respiratory specimens is speciﬁc for CF patients,
BAL ﬂuids from six children suffering from pulmonary dis-
eases other than CF were assessed for obligate anaerobes.
Three of the patients had sterile lungs. In BAL ﬂuids of the
three other patients, low numbers of Streptococcus spp. and
other aerobic bacteria (£4 · 104 CFU/mL), which possibly
represent upper-airway contamination [19,20], were
detected. BAL ﬂuid from only one patient with chronic
retention pneumonia yielded obligate anaerobic bacteria. In
the purulent secretions from this patient, the facultative
anaerobe S. aureus (2 · 102 CFU/mL) was detected, along
with the obligate anaerobic species Staphylococcus saccharolyti-
cus (1 · 102 CFU/mL). The results suggest that, under anaer-
obic conditions, large volumes of sputum are needed to
allow proliferation of obligate anaerobes to reach the num-
bers found in CF patients (see below).
Next, it was investigated whether obligate anaerobes con-
tribute to the pathophysiology of CF lung disease by affecting
lung function. Lung function values did not differ signiﬁcantly
between patients with and those without obligate anaerobes
(FEV1, p = 0.087; FVC, p = 0.880).
Cell numbers of facultative and obligate anaerobic bacteria
in sputum samples of CF patients and comparison with
bacteria isolated from throat swabs
To investigate whether cell numbers of obligate anaerobes in
CF airways were comparable to those of P. aeruginosa or
S. aureus, a quantitative microbiological determination was
carried out. Cell numbers of facultative (mean:
5.5 · 107 CFU/mL) and obligate (mean: 2.2 · 107 CFU/mL)
anaerobic bacteria in sputum samples of CF patients were
high and within comparable ranges (Fig. 1). In contrast, obli-
gate anaerobes were detected from throat swabs in low
numbers (7.5 · 103 ± 1.1 · 104 CFU/mL) and in only three
of seven patients. To answer the question of whether the
presence of obligate anaerobes would inﬂuence cell numbers
of P. aeruginosa or S. aureus, facultative and obligate anaerobe
counts were compared in all sputum samples. P. aeruginosa
cell numbers in sputum specimens with and without obligate
anaerobes did not differ signiﬁcantly (p = 0.970). A similar
result was obtained when S. aureus cell numbers were com-
pared in sputum specimens with and without obligate anaer-
obes (p = 0.230). Furthermore, the numbers of obligate
anaerobes in sputum samples with P. aeruginosa or S. aureus
did not differ signiﬁcantly (p = 0.176).
Impact of P. aeruginosa-speciﬁc antibiotic therapy during
acute exacerbations on cell numbers of obligate anaerobes
and lung function, and antibiotic resistance patterns of
obligate anaerobes in CF respiratory specimens
To test the impact of antibiotic therapy, directed against
P. aeruginosa during acute exacerbations, on numbers of obli-
gate anaerobes in CF respiratory specimens and on lung
function, cell numbers of obligate anaerobes were deter-
mined in 12 CF patients before and after P. aeruginosa-spe-
ciﬁc antibiotic therapy. In sputum samples of all patients,
obligate anaerobes were found before and after antibiotic
therapy. The number of obligate anaerobes did not decrease
signiﬁcantly after therapy, and the numbers of facultative
anaerobes did not change (Fig. 2a). In seven of 12 patients,
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FIG. 1. Equivalence of facultative and obligate anaerobic bacterial
cell numbers in respiratory specimens of cystic ﬁbrosis (CF) patients.
Cell numbers of facultative and obligate anaerobes were evaluated in
41 sputum samples and seven throat swabs obtained from CF
patients.
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one or more obligate anaerobes were detected that were
resistant to the respective antibiotics used for treatment of
acute exacerbations. However, FEV1 increased signiﬁcantly
after therapy (p = 0.012), and a trend towards improvement
was observed with respect to FVC, reﬂecting an improved
clinical condition (Fig. 2b).
To assess the antibiotic resistance patterns of obligate
anaerobes, susceptibility testing using the Etest was per-
formed for 138 obligate anaerobic strains isolated from CF
sputum specimens (Table 2). Only 3.6% of the obligate
anaerobic strains tested were resistant to meropenem.
Much larger variability was observed in the resistance to
piperacillin–tazobactam, clindamycin, metronidazole and ceft-
azidime. Ceftazidime was the least active antibiotic with
regard to obligate anaerobes (Table 2).
Discussion
In the vast majority of sputum samples from CF patients, a
large variety of obligate anaerobic genera is present, indepen-
dently of the age of the patient. Up to four different species
were found in single sputum samples. The presence of low
numbers of obligate anaerobes in throat swabs of CF
patients suggests that the oral cavity is the niche from which
obligate anaerobes spread into the lower airways, where
they proliferate in the anaerobic sputum plugs. These ﬁndings
partly corroborate previous studies showing a high diversity
of obligate anaerobes in sputum as well as in BAL ﬂuid.
Although bacterial numbers in BAL ﬂuid were lower, the
identiﬁcation of speciﬁc bacteria corresponded well with that
of the bacteria found in the sputum of the respective
patients [16]. However, other species were dominant in the
airways of CF patients attending the CF centre in Halle, as
compared to those in other studies [14–16]. Speciﬁcally, a
high prevalence of Prevotella spp. was not found. Rather, dif-
ferent species of Staphylococcus and Peptostreptococcus were
predominant. This may be due to regional differences in spe-
cies prevalence, or differences in the identiﬁcation techniques
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FIG. 2. Antibiotic therapy for acute exacerbations does not inﬂuence
sputum cell numbers of facultative and obligate anaerobic bacteria, but
does lead to an increase in lung function. Sputum bacterial counts of
facultative and obligate anaerobes (a), forced expiratory volume in 1 s
(FEV1) and forced vital capacity (FVC) (b) in 12 cystic ﬁbrosis patients
suffering from acute exacerbations before ( ) and after (h) intravenous
Pseudomonas aeruginosa-speciﬁc antibiotic therapy.
TABLE 2. Antibiotic susceptibilities of obligate anaerobes
Species Strains tested
No. of resistant strains (%)
PTC CM MZ MP TZ
Peptostreptococcus spp. 32 2 (6) 5 (16) 26 (81) 0 (0) 7 (22)
Staphylococcus saccharolyticus 25 14 (56) 1 (4) 2 (8) 1 (4) 24 (96)
Actinomyces spp. 18 0 (0) 7 (39) 9 (50) 2 (11) 8 (44)
Veillonella spp. 14 8 (57) 1 (7) 4 (29) 0 (0) 11 (79)
Streptococcus spp. 10 0 (0) 4 (40) 10 (100) 0 (0) 2 (20)
Clostridium spp. 9 0 (0) 4 (44) 3 (33) 1 (11) 4 (44)
Bacteroides spp. 8 0 (0) 3 (37) 0 (0) 0 (0) 6 (75)
Propionibacterium spp. 3 0 0 3 0 0
Lactobacillus spp. 3 0 3 0 0 0
Eubacterium spp. 3 0 1 2 0 3
Gemella morbillorum 3 0 2 2 0 1
Prevotella spp. 3 0 0 0 0 2
Mobiluncus spp. 3 0 0 2 0 0
Capnocytophaga spp. 2 0 1 2 1 1
Wolinella spp. 2 2 0 2 0 2
Total 138 18.8% 23.2% 48.6% 3.6% 51.4%
458 Clinical Microbiology and Infection, Volume 15 Number 5, May 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 454–460
used. For example, in the present study, the use of antibi-
otic-containing culture media for growing obligate anaerobes
was abandoned. In addition, taxonomy and nomenclature of
the obligate anaerobes are subject to continuous modiﬁca-
tions [21]. Obligate anaerobes were also found to persist in
CF airways for longer periods of time.
The present results also indicate that infection with P. aeru-
ginosa does not signiﬁcantly increase the likelihood that
anaerobic bacteria are present in CF sputum specimens, as
reported previously [16], as obligate anaerobes were also
found in sputum specimens from patients infected with other
facultative anaerobic species, e.g. S. aureus. Furthermore, the
presence of obligate anaerobes does not reduce or increase
the cell numbers of P. aeruginosa or S. aureus, as no correla-
tions were found when facultative and obligate anaerobes
were quantiﬁed in sputum specimens of CF patients. Thus,
the presence of large anaerobic sputum volumes is essential
to allow obligate anaerobes to prevail in the airways of CF
patients. This notion is further supported by the ﬁnding that
obligate anaerobes were found, in low cell numbers, in BAL
ﬂuids of only one of six patients suffering from other pulmo-
nary diseases. Only this single patient expectorated small
amounts of purulent sputum. BAL samples were used, as the
children would not spontaneously produce sputum, and as
the detection limit for bacteria in BAL ﬂuid is low (101 CFU/
mL). Possibly, obligate anaerobes can also be detected in the
lungs of patients with other chronic lung diseases associated
with sputum production, e.g. chronic obstructive lung
disease.
The question of whether obligate anaerobes play a role in
the pathophysiology of CF lung disease affecting lung function
could not be sufﬁciently answered at the end of this study.
Although lung function values did not differ signiﬁcantly
between patients with and those without obligate anaerobes
in their airways, it is far too early to conclude that obligate
anaerobes do not contribute to CF lung disease. Further
studies, e.g. using antibiotics targeted speciﬁcally to obligate
anaerobes, may be more informative.
Antibiotic therapy directed against P. aeruginosa did not
reduce the numbers of obligate anaerobes in CF respiratory
specimens. This may be a reﬂection of the fact that 58% of
the patients harboured obligate anaerobes that were resis-
tant to the antibiotics used for the treatment of acute exac-
erbations. When these experiments were enlarged to
include 138 obligate anaerobic strains, a much larger variabil-
ity in resistance to piperacillin–tazobactam, clindamycin, met-
ronidazole and ceftazidime was observed, with the exception
of meropenem, to which only 3.6% of all obligate anaerobic
strains tested were resistant. A similar result was also found
by Tunney et al. [16].
However, FEV1 increased signiﬁcantly after therapy. This
ﬁnding may also be interpreted as meaning that obligate
anaerobes play no role in the pathphysiology of CF lung dis-
ease. However, P. aeruginosa-speciﬁc antibiotics did not affect
the cell numbers of facultative anaerobes, a phenomenon
that requires further investigation.
Taken together, these data demonstrate that obligate
anaerobes are present in the airways of the vast majority of
chronically infected CF patients. If obligate anaerobic bacteria
contribute to inﬂammation and damage in the CF lung,
altered antibiotic therapy, optimized to target anaerobes in
addition to the primary infecting pathogens, may improve the
management of CF patients.
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